ORMP Oramed Pharmaceuticals Inc. Future Profit

Official company branding of Oramed (ORMP)

The analytical profit forecast for Oramed Pharmaceuticals (ORMP) demonstrates stability, supported by Nadav Kidron's competent leadership and solid reserves. The operating model is based on the full outsourcing of capsule production to third-party contractors. However, intense competition in the oral insulin segment creates significant risks. The value of indicates the level of this metric, helping to assess the balance between growth potential and a possible correction.

Oramed Pharmaceuticals (ORMP): Expected Net Profit from 07/04/2022 to 11/16/2026

Oramed - analytical breakdowns and key metrics (ORMP)

- share price and consensus valuation forecast:
Fundamental company analysis:ORMP, Oramed
Finished products of Oramed Pharmaceuticals Inc.

This indicator synthesizes market expectations and financial forecasts to determine the asset's fair value. It reflects the balance of supply and demand, assessing business resilience to external shocks through the dynamics of future earnings. For Oramed Pharmaceuticals (ORMP), this metric is based on long-term royalties from the licensing of patents for oral drug delivery. By analyzing target profit figures, an investor evaluates the monetization potential of the intellectual property. The stability of these values confirms the company's protection against inflationary risks.

Competitor analysis for Oramed Pharmaceuticals

Future Profit HLN|Projected Future Earnings Kenvue Corp|Future Profit VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Expected Net Income|Expected Profit Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Expected Net Profit|PRGO: Future Profit|Alvotech SA - Future Net Profit|LQDA: Projected Future Earnings|Galapagos Genomics - Expected Net Income|ANIP (ANI Pharmaceuticals Inc) - Projected Future Earnings|Expected Net Profit mannkindcorp.com MNKD|Expected Profit Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Expected Net Income|Projected Future Earnings SPRY (ARS Pharmaceuticals Inc)|Future Net Profit TBPH (Theravance)|AQST - Expected Profit|scPharmaceuticals (SCPH) - Future Profit|TECX: Projected Future Earnings|Net Profit Forecast TNXP|Expected Profit China SXT Pharmaceuticals, Inc.|EPRX: Expected Net Income|Projected Future Earnings BHST|EXOZ - Expected Net Profit|Projected Future Earnings ENTX (Entera Bio Ltd)|Projected Future Earnings MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Projected Future Earnings|CPIX: Expected Profit|QNTM (Quantum BioPharma Ltd) - Future Profit|Net Profit Forecast FGEN|Expected Profit Telomir Pharmaceuticals|RANI: Expected Net Income|Projected Future Earnings SNYR|Future Profit Rallybio Corp RLYB|Expected Profit Lexaria Bioscience Corp. LEXX|Company Profit Forecast pulmatrix.com (PULM)|Pheton Holdings Limited - Projected Future Earnings|Forward Earnings APM|LYRA (Lyra Therapeutics Inc.) - Future Profit|IBO - Company Profit Forecast|Future Profit TNFA|Net Profit Forecast YCBD (cbdmd.com)|Future Profit PRFX (PainReform Ltd)|CYTO: Forward Earnings|Projected Future Earnings LIPO (lipella.com)|Future Net Profit OPTN (OptiNose Corp)|PIRS: Future Profit|PROC - Projected Future Earnings|PTPI: Projected Future Earnings|Qilian International Holding Group (QLI) - Projected Future Earnings|SLRN (ACELYRIN, Inc.) - Projected Future Earnings|TFF Pharmaceuticals (TFFP) - Company Profit Forecast